Concepedia

Remi Adelaiye‐Ogala

RA

Statistics

Publications

19

Citations

1.4K

H-Index

15

Active since

2011

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

University of Turin

Indiana University – Purdue University Indianapolis

Indiana University Health

University at Buffalo, State University of New York

Remi Adelaiye‐Ogala is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, oncology, and tumor biology.

ORCID

Top concepts

Publications per year

2011–2023

19

Publications

19

Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma

Ashley Orillion, Ayumi Hashimoto, Nur P. Damayanti et al. · Clinical Cancer Research · 2017 · 355 citations · Full text

Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer

Luigi Fontana, Remi Adelaiye‐Ogala, Antonella Rastelli et al. · Oncotarget · 2013 · 127 citations · Full text

Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy

Ashley Orillion, Nur P. Damayanti, Li Shen et al. · Clinical Cancer Research · 2018 · 106 citations · Full text

Combination of the histone deacetylase inhibitor vorinostat with bevacizumab in patients with clear-cell renal cell carcinoma: a multicentre, single-arm phase I/II clinical trial

Glenn Liu, Sreenivasulu Chintala, Shabnam Rehman et al. · British Journal of Cancer · 2017 · 99 citations · Full text

Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models

Eric Ciamporcero, Kiersten Marie Miles, Remi Adelaiye‐Ogala et al. · Molecular Cancer Therapeutics · 2014 · 92 citations · Full text

, , +19

1–5 of 19